| Literature DB >> 33193705 |
Yee-Shan Ku1, Carolina A Contador1, Ming-Sin Ng1, Jeongjun Yu2, Gyuhwa Chung2, Hon-Ming Lam1.
Abstract
Legumes are rich in secondary metabolites, such as polyphenols, alkaloids, and saponins, which are important defense compounds to protect the plant against herbivores and pathogens, and act as signaling molecules between the plant and its biotic environment. Legume-sourced secondary metabolites are well known for their potential benefits to human health as pharmaceuticals and nutraceuticals. During domestication, the color, smell, and taste of crop plants have been the focus of artificial selection by breeders. Since these agronomic traits are regulated by secondary metabolites, the basis behind the genomic evolution was the selection of the secondary metabolite composition. In this review, we will discuss the classification, occurrence, and health benefits of secondary metabolites in legumes. The differences in their profiles between wild legumes and their cultivated counterparts will be investigated to trace the possible effects of domestication on secondary metabolite compositions, and the advantages and drawbacks of such modifications. The changes in secondary metabolite contents will also be discussed at the genetic level to examine the genes responsible for determining the secondary metabolite composition that might have been lost due to domestication. Understanding these genes would enable breeding programs and metabolic engineering to produce legume varieties with favorable secondary metabolite profiles for facilitating adaptations to a changing climate, promoting beneficial interactions with biotic factors, and enhancing health-beneficial secondary metabolite contents for human consumption.Entities:
Keywords: defense; domestication; health benefit; legume; secondary metabolite
Year: 2020 PMID: 33193705 PMCID: PMC7530298 DOI: 10.3389/fgene.2020.581357
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Classification of secondary metabolites in legumes and their benefits to human health.
| Groups | Sub-groups | Examples in legumes | Occurrence in legumes | Benefit(s) to human health | References |
|---|---|---|---|---|---|
| Polyphenols | Flavonoids | Quercetin, kaempferol | Widely distributed | Reduction in ischemic heart disease, reduction in body weight | ( |
| Isoflavones | Genistein, daidzin | Soybean seeds | Phytoestrogen, antioxidant, antimicrobial and anti-inflammatory properties, reduction of risk in cardiovascular diseases, diabetes, obesity, and osteoporosis | ( | |
| Catechin | Catechin, epicatechin, gallo-catechin | Broad bean, chickpea, cowpea, kidney-bean, lentil, peanut | Reduction in heart disease, improvement of sperm motility and viability | ( | |
| Anthocyanins | Pelargonidin, cyanidin, malvidin, petunidin | Widely distributed | Antioxidant and anti-inflammatory properties, lipid peroxidation, DNA cleavage protection | ( | |
| Terpenoids and steroid | Triterpenoid saponins | Saponins | Chickpea, soybean, lentils, peanut, common bean, and alfalfa sprouts | Reduction of cholesterol content, antimicrobial and anti-cancer properties | ( |
| Tetraterpenes | Carotenoids | Widely distributed | Antioxidant, better visual function, reduction of cardiovascular diseases | ( | |
| Alkaloids | Quinolizidine alkaloids (QA) | Sparteine | Antimicrobial properties | ( | |
| Pyrroloindole alkaloids | Physostigmine | Ordeal bean | Treatment of Alzheimer’s disease and Parkinson’s disease | ( | |
| Peptides | Polypeptide | Lunasin | Soybean | anti-inflammatory properties, reduction of cholesterol content, antioxidant, anticancer and anti-atherosclerotic activities | ( |
| Protease inhibitors | Angiotensin-I converting enzyme inhibitors | Pea, chickpea, mung bean, soybean, lentil | Lowering blood pressure and risk of heart failure | ( | |
| Amines | Polyamine | spermine, spermidine | Common bean, white clover, mung bean | Antioxidant activities, reduction of cardiovascular diseases | ( |
Figure 1Schematic representation of the flavonoid biosynthetic pathway. Enzymes involved in the pathway are indicated in bold: chalcone synthase (CHS), chalcone reductase (CHR), flavone 3-hydroxylase (F3H), flavonoid 3'-hydroxylase (F3'H), flavonoid 3',5'-hydroxylase (F3'5'H), dihydroflavonol 4-reductase (DFR), and anthocyanidin synthase (ANS).
Figure 2Schematic representation of the pathway leading to the synthesis of quinolizidine alkaloid compounds. Enzymes involved in the pathway are indicated in bold: lysine decarboxylase (LDC), copper amine oxidase (CuAO), (+)-epilupinine O-coumaroyltransferase (ECT), (+)-epilupinine feruloyltransferase (EFT), (−)-lupinine O-coumaroyltransferase (LCT), (−)-lupinine feruloyltransferase (LFT), (−)-13α-hydroxymultiflorine transferase (HMT), and (+)-13α-hydroxylupanine O-tigloyltransferas (HLT).
Figure 3Schematic representation of the pathway leading to the synthesis of (+)-pisatin and (−)-maackiain. Enzymes involved in the pathway are indicated in bold: isoflavone reductase (IFR), sophorol reductase (SOR), (+)-6α-hydroxymaackiain 3-O-methyltransferase (HMM2), and hydroxisoflavanol dehydratase (HILD). The steps to convert (−)-7,2'-dihydroxy-4',5'-methylenedioxyisoflavanol (DMDI) to (+)-6α-hydroxymaackiain are unknown (dotted arrow).